Suppr超能文献

神经外科领域的随机对照试验——我们做得有多好?

Randomized controlled trials in neurosurgery--how good are we?

作者信息

Schöller K, Licht S, Tonn J-C, Uhl E

机构信息

Department of Neurosurgery, University of Munich Medical Center, Grosshadern Marchioninistr. 15, 81377, Munich, Germany.

出版信息

Acta Neurochir (Wien). 2009 May;151(5):519-27; discussion 527. doi: 10.1007/s00701-009-0280-y. Epub 2009 Apr 1.

Abstract

BACKGROUND

The strongest evidence in medical clinical literature is represented by randomized controlled trials (RCTs). This study was designed to evaluate neurosurgically relevant RCTs published recently by neurosurgeons.

METHOD

A literature search in MEDLINE and EMBASE included all clinical studies published up to 30 June 2006. RCTs with neurosurgical relevance published by at least one author with affiliation to a neurosurgical department were selected. The number and characteristics of individual trials were recorded, and the quality of the trials with regard to study design, quality of reporting, and relevance for clinical practice was assessed by two different investigators using a modification of the Scottish Intercollegiate Guidelines Network methodology checklist. Changes of RCT quality over time as well as factors influencing the quality were analyzed.

FINDINGS

From the initial search results (MEDLINE n = 3,860, EMBASE n = 3,113 articles), 159 RCTs published by neurosurgeons were extracted for final evaluation. Of the RCTs, 62% have been published since 1995; 52% came from the USA, UK, and Germany. The median RCT sample size was 78 patients and the median follow-up 35.7 weeks. Fifty-two percent of all RCTs were of good, 37% of moderate, and 11% of bad quality, with an improvement over time. RCTs with financial funding and RCTs with a sample size of >78 patients were of significantly better quality. There were no major differences in the rating of the studies between the two investigators.

CONCLUSIONS

Only a fraction of neurosurgically relevant literature consists of RCTs, but the quality is satisfying and has significantly improved over the last years. An adequate sample size and sufficient financial support seem to be of substantial importance with regard to the quality of the study. Our data also show that by using a standardized checklist, the quality of trials can be reliably assessed by observers of different experience and educational levels.

摘要

背景

医学临床文献中最有力的证据由随机对照试验(RCT)呈现。本研究旨在评估神经外科医生近期发表的与神经外科相关的随机对照试验。

方法

在MEDLINE和EMBASE中进行文献检索,纳入截至2006年6月30日发表的所有临床研究。选取至少有一位作者隶属于神经外科科室且与神经外科相关的随机对照试验。记录各个试验的数量和特征,并由两名不同的研究者使用苏格兰校际指南网络方法检查表的修改版,评估试验在研究设计、报告质量和临床实践相关性方面的质量。分析随机对照试验质量随时间的变化以及影响质量的因素。

结果

从最初的检索结果(MEDLINE中有3860篇文章,EMBASE中有3113篇文章)中,提取了159篇由神经外科医生发表的随机对照试验进行最终评估。在这些随机对照试验中,62%是1995年以后发表的;52%来自美国、英国和德国。随机对照试验的样本量中位数为78例患者,随访中位数为35.7周。所有随机对照试验中,52%质量良好,37%质量中等,11%质量较差,且质量随时间有所改善。有资金资助的随机对照试验以及样本量大于78例患者的随机对照试验质量明显更好。两位研究者对研究的评分没有重大差异。

结论

与神经外科相关的文献中只有一小部分是随机对照试验,但质量令人满意,且在过去几年中有显著提高。足够的样本量和充足的资金支持对于研究质量似乎至关重要。我们的数据还表明,通过使用标准化检查表,不同经验和教育水平的观察者能够可靠地评估试验质量。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验